Table of contents

PostScript

• Letter: Antibiotic use and inflammatory bowel disease: number needed to harm? (21 February, 2023)

  Jonas F Ludvigsson
• Letter: Sucrase-isomaltase genotype and response to a starch-reduced and sucrose-reduced diet in IBS-D patients (6 March, 2023)

  Andreea Zamfir-Taranu, Britt-Sabina Löscher, Diab M. Husein, Abdullah Hoter, Koldo Garcia-Etxebarria, Usune Etxeberria, Lucía Gayoso, Gabriele Mayr, Clara Nilholm, Rita J. Gustafsson, Oliver Ozaydin, Tenghao Zheng, Cristina Esteban-Blanco, Isotta Bozzarelli, Ferdinando Bonfiglio, Sandra Rizk, Andre Franke, Luis Bujanda, Hassan Y. Naim, Bodil Ohlsson, Mauro D'Amato
• Letter:

  Empiric use of standard triple therapy in Helicobacter pylori eradication does not require readjustment in the clarithromycin resistance cut-off point

  (6 March, 2023)

  Peter Malfertheiner, Francis Megraud, Theodore Rokkas, Javier P Gisbert
• Letter:

  ‘Family-based’ strategy for Helicobacter pylori infection screening: an efficient alternative to ‘test and treat’ strategy

  (7 March, 2023)

  Jiafeng Zhang, Yuchen Deng, Chang Liu, Huiquan Wang, Heifei Ren, Sai Chen, Lei Chen, Bin Shi, Lin Zhou
• Letter: Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments (6 March, 2023)

  Eva Zhang, Thi H O Nguyen, Lilith F Allen, Lukasz Kedzierski, Louise C Rowntree, So Young Chang, Wuji Zhang, Jennifer R Habel, Isabelle J Foo, Tejas Menon, Jeni Mitchell, Rupert W Leong, Katherine Bond, Deborah A Williamson, Katherine Kedzierska, Britt Christensen